“parkinsons-disease” Archives

Entry Author Date Location
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More 01/13/12 Boston
Civitas Charts Positive Data on Inhaled Parkinson’s Drug 01/06/12 Boston
Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines 12/02/11 Boston
Rib-X, Skyhook, Michael J. Fox Foundation & More Boston-Area Deals News 11/30/11 Boston
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug 11/29/11 Boston
23andMe Identifies Possible Protective Gene Against Parkinson’s Disease 10/25/11 San Diego
NIH Awards $2.1M grant for Parkinson’s Research at Wayne State University 09/26/11 Detroit Ann Arbor
Neurologix Forges Ahead on Gene Therapy Treatment for Parkinson’s 06/23/11 New York
NeuroHealing Repurposes Drugs, Resulting in Potential New Remedies For CNS Disorders 06/02/11 Boston
23andMe Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma 05/24/11 San Francisco
Prexa Pulls In $7M From Advent, Shire 05/11/11 Boston
Acadia Raises $15M 01/10/11 San Diego
Alkermes Finds New Home For Inhaled Drug-Delivery Tech with Civitas Spinout 01/10/11 Boston
Boston Scientific Buys Intelect 01/05/11 Boston
Biogen Idec Buys Drug Rights from Neurimmune for $32.5M 12/21/10 Boston
Ceregene Adds $11.5M 11/11/10 San Diego
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News 10/15/10 San Francisco
Synosia Raises $30M, Strikes Deal With UCB Worth Up to $725M for Parkinson’s Drugs 10/12/10 San Francisco
Intrigue, Fraud Surround Death of Biotech Angel Investor, Neurocrine Biosciences Signs Two Big Deals, Regulus Therapeutics Signs Sanofi-Aventis Deal, & More San Diego Life Sciences News 06/24/10 San Diego
Ceregene Gets $2.5M From Fox Foundation 06/23/10 San Diego
San Diego’s Neurocrine Biosciences Scores Second Big Deal in Two Days 06/18/10 San Diego
FoldRx Pharma Finds $29M, Plans to Seek Approval of First Drug in 2010 06/15/10 Boston
Avalon Raising New Fund, Althea Technologies Gets Altus Assets, Trancon Pharmaceuticals Nabs Financing, & More San Diego Life Sciences News 05/06/10 San Diego
Link Medicine Ups Third Round to $45M, Taking Aim at Alzheimer’s and Parkinson’s 05/04/10 Boston
Acadia Pharma Shares Crash After Lead Parkinson’s Drug Fails in Trial 09/01/09 San Diego
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say 08/26/09 Seattle
Acadia Files Shelf Registration 08/10/09 San Diego
Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News 08/06/09 San Diego
No More Tears: Avanir Investors Await Trial Results on Emotional Outburst Drug 07/23/09 San Diego
San Diego’s Acadia Awaits Parkinson’s Trial Results (and a Chance to Prove Naysayers Wrong) 05/19/09 San Diego
Page 2 of 3 « previous page · next page »